amikacin has been researched along with cefoxitin in 101 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 34 (33.66) | 18.7374 |
1990's | 6 (5.94) | 18.2507 |
2000's | 30 (29.70) | 29.6817 |
2010's | 26 (25.74) | 24.3611 |
2020's | 5 (4.95) | 2.80 |
Authors | Studies |
---|---|
Barth, AL; Castanheira, M; Gales, AC; Nicoletti, AG; Pereira, AS; Pignatari, AC | 1 |
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
Cauda, R; Citton, R; D'Inzeo, T; Fadda, G; Fiori, B; Montuori, E; Posteraro, B; Sanguinetti, M; Spanu, T; Trecarichi, EM; Tumbarello, M | 1 |
Avlami, A; Daikos, GL; Katsilambros, N; Kosmidis, C; Petrikkos, G; Psychogiou, M; Stefanou, I; Tassios, PT; Vasilakopoulou, A | 1 |
Bille, J; Lartigue, MF; Nordmann, P; Poirel, L; Wenger, A; Zinsius, C | 1 |
Afkou, Z; Ikonomidis, A; Labrou, M; Maniatis, AN; Pournaras, S; Sofianou, D; Tsakris, A | 1 |
Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
Byrd, TF; Greendyke, R | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Alba, V; Blasco, MD; Espinal, P; Fernández-Cuenca, F; Marti, S; Pascual, A; Ruiz, M; Sánchez-Céspedes, J; Vila, J | 1 |
Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
Amsler, KM; Bush, K; Davies, TA; Jacobs, MR; Shang, W | 1 |
Esteban, J; Fernández-Martínez, AI; Fernández-Roblas, R; Gadea, I; García-Almeida, D; Martín-de-Hijas, NZ | 1 |
Chen, H; Chen, M; Wang, H; Yang, H; Yang, Q | 1 |
Bennett, JW; Herrera, ML; Jorgensen, JH; Lewis, JS; Wickes, BW | 1 |
Chang, FY; Chen, JH; Fung, CP; Lai, YK; Lin, CJ; Lin, JC; Ma, L; Siu, LK | 1 |
Andlovic, A; Jeverica, S; Karisik, E; Koren, S; Krizan-Hergouth, V; Livermore, DM; Mesko Meglic, K; Müller-Premru, M; Palepou, MF; Pike, R; Seme, K; Woodford, N | 1 |
Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C | 1 |
Bell, JM; Castanheira, M; Deshpande, LM; Jones, RN; Mendes, RE; Turnidge, JD | 1 |
Bell, JM; Castanheira, M; Jones, RN; Mathai, D; Turnidge, JD | 1 |
Baraniak, A; Bedenic, B; Fiett, J; Gniadkowski, M; Jajic-Bencic, I; Literacka, E; Tonkic, M | 1 |
Guo, Q; Hooper, DC; Wang, M; Wang, X; Wu, S; Xu, X; Ye, X | 1 |
Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ; Hsueh, PR; Paterson, DL | 1 |
Du, X; Ji, S; Jiang, Y; Li, L; Shen, P; Wei, Z; Yu, Y | 1 |
Carattoli, A; Ellington, MJ; Karisik, E; Livermore, DM; Underwood, A; Woodford, N | 1 |
Chen, H; Chen, M; Sun, H; Wang, H; Xu, Y; Yang, Q | 1 |
Badal, RE; Bouchillon, SK; DiPersio, J; Hawser, SP; Hoban, DJ; Labombardi, VJ | 1 |
Jiang, Y; Shen, P; Wei, Z; Yu, D; Yu, Y; Zhou, Z | 1 |
Hamprecht, A; Higgins, PG; Schneiders, T; Seifert, H | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
George, WL; Lewis, RP; Meyer, RD | 1 |
Hirshman, HP; Nagel, DA; Schurman, DJ | 1 |
Shah, PM; Stille, W | 1 |
Ball, P; Gray, J | 1 |
Bartlett, M; Crane, JK; Griffin, PS; Miller, MA; Yousuf, M | 1 |
Yoshikawa, TT | 1 |
Benard, Y; Bergogne-Berezin, E; Berthelot, G; Even, P; Kafe, H; Lambert-Zechovsky, N; Morel, C; Pierre, J | 1 |
Busch, DF; Finegold, SM; Sutter, VL | 1 |
Singh, N; Yu, VL | 1 |
Bertrand, H; Boulanger-Ferre, F; Descottes, B; Desport, JC; Devalois, B; Mercury, P; Peze, P; Sardin, B | 1 |
Nelson, BR; Rapini, RP; Tschen, JA; Wallace, RJ | 1 |
Despres, B; Soper, DE | 1 |
Orefici, G; Scopetti, F | 1 |
Asano, Y; Imanaka, K; Koyanagi, T; Miyabe, N; Nagamori, S; Sakashita, S; Shinno, Y; Takahashi, Y; Tubo, S | 1 |
Hoshino, K; Hotta, Y; Kawakami, K; Kita, K; Kobayashi, T; Mori, M; Nosaka, T; Ohta, C; Uchiyama, S; Uno, N | 1 |
Bullen, MG; Silcox, VA; Swenson, JM; Wallace, RJ | 1 |
Aguado-Matorras, A; Garcia-Caballero, J; Martinez-Forde, JM | 1 |
McNamara, BT; Meyer, RD; Pasiecznik, KA | 1 |
Borrás, R; Brines, J; Escribano, A; Hernández, R; Lloret, J; Martínez Costa, C; Nogueira, JM | 1 |
Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR | 1 |
Brockmeier, D; Marget, W; Roos, R; von Hattingberg, HM | 1 |
Alvarez, S; DeMaria, A; Klein, JO; McCabe, WR | 1 |
Carpenter, JL; Troxell, M; Wallace, RJ | 1 |
Caretti, D; Escudero, A; Fernández-Garese, D; Fernández-Rañada, J; Olmeda, F; Vázquez, L | 1 |
Kawabata, S; Nishino, T; Tanaka, M; Tanino, T | 1 |
Ogawa, H; Osada, Y; Une, T | 1 |
Schrettenbrunner, A; Schröter, G | 1 |
Trollfors, B | 1 |
Gorbach, SL; Kellum, JM; McGowan, K; O'Donnell, TF; Tally, FP | 1 |
Gorbach, SL; McGowan, K | 1 |
Haas, H; Michel, J; Sacks, TG | 1 |
Shah, PM; Siegel, K; Stille, W | 1 |
Ichimaru, M; Yamaguchi, H | 1 |
Luper, WE; Martin, RF; Phillips, LE; Rogers, TE | 1 |
Gorbach, SL; McGowan, K; Scheife, RT; Tally, FP | 1 |
Eckhoff, DG; Pring, M | 1 |
Garces, MC; Liening, DA; McAllister, CK; Plemmons, RM | 1 |
Das De, S; Thiagarajan, P | 1 |
Bergmann, JS; Boulet, B; Brown, BA; Fahle, GA; Plaunt, M; Wallace, RJ; Wanger, A; Witebsky, FG; Woods, GL | 1 |
Wang, CK; Yang, CH | 1 |
Avery, RK; Mossad, SB; Tejan-Sie, SA | 1 |
Kasai, S; Nishiyama, H; Tokuda, H; Yoshikawa, M | 1 |
Campo, C; Campos-Herrero, MI; Figuerola, A; García, D; García, MJ; Suárez, P | 1 |
Jackson, MA; Selvarangan, R; Sharma, M; Thorell, EA; Woods, GM | 1 |
Jeon, K; Kim, BJ; Kim, CK; Koh, WJ; Kook, YH; Kwon, OJ; Lee, NY; Lee, SH; Park, YK | 1 |
Daley, CL; Huitt, GA; Jeon, K; Kim, BJ; Kim, CK; Koh, WJ; Kook, YH; Kwon, OJ; Lee, NY; Lee, SH; Park, YK; Shin, SJ | 1 |
Bonne, S; Legout, L; Prevotat, A; Senneville, E; Veziris, N; Yazdanpanah, Y | 1 |
Chae, JY; Kim, JW; Moon, du G; Oh, MM; Park, MG; Yoon, CY | 1 |
Cai, L; Li, CY; Liu, ZH; Sun, ZG; Zhang, JZ; Zhou, C; Zhuo, FL | 1 |
Gui, J; Hong, CY; Li, JL; Liang, J; Wang, F | 1 |
Belghiti, J; Bert, F; Dondero, F; Durand, F; Larroque, B; Moreau, R; Nicolas-Chanoine, MH; Paugam-Burtz, C | 1 |
Chu, N; Duan, H; Huang, H; Lu, Y; Nie, W | 1 |
Gentry, CA; Williams, RJ | 1 |
Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
Frew, JW; Nguyen, RT | 1 |
Daley, CL; Huh, HJ; Jeon, K; Jeong, BH; Ki, CS; Kim, CK; Kim, H; Kim, SY; Koh, WJ; Kwon, OJ; Lee, NY; Lee, SH; Park, HY; Park, KU; Shin, SJ | 1 |
Deshpande, D; Ferro, BE; Gumbo, T; Mouton, JW; Pasipanodya, JG; Srivastava, S; van Ingen, J; van Soolingen, D | 1 |
Bouziane, F; Cambau, E; Chau, F; Crockett, F; Mougari, F; Nessar, R; Raskine, L; Sapriel, G; Veziris, N | 1 |
Alp, E; Badal, R; Gulay, Z; Koksal, I; Korten, V; Lob, S; Mete, B; Mulazimoglu, L; Oguz, VA; Tabak, F; Unal, S; Yilmaz, G; Zarakolu, P | 1 |
Lu, J; Pang, Y; Song, Y; Zhang, Z | 1 |
Liu, Y; Pan, L; Wang, Y | 1 |
Cai, SCS; Chan, W; Ling, KL; Low, JGH; Shim, HH; Tan, HH | 1 |
Ejaz, A; Ejaz, H; Javed, H; Saleem, R; Younas, S; Zafar, A | 1 |
Guo, H; Jiang, Z; Ju, Z; Qiu, J; Sun, S; Yang, J; Zhao, X | 1 |
Jevert-Eichorn, S; Radigan, A | 1 |
da Silva, FFM; de Brito, RC; de Melo, TR; do Amaral, FLE; Farias, TC; Ferreira, PB; Ferreira, SB; Lima, ZN | 1 |
Gu, KM; Kim, JY; Kwak, N; Park, J; Yim, JJ; Yoon, SH | 1 |
Chen, J; Liu, W; Zhao, F | 1 |
Ammerman, NC; Bax, HI; de Steenwinkel, JEM; de Vogel, CP; Mudde, SE; Schildkraut, JA; van Ingen, J | 1 |
Arslan, N; Esen, N; Özkarataş, MH; Özkütük, AA | 1 |
4 review(s) available for amikacin and cefoxitin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Successful treatment of pulmonary infection due to Mycobacterium chelonae: case report and review.
Topics: Amikacin; Cefoxitin; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Lung Diseases; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Sputum; Tomography, X-Ray Computed | 1992 |
Comparative clinical trials in treatment of intra-abdominal sepsis.
Topics: Abdomen; Abdominal Injuries; Abscess; Amikacin; Animals; Bacterial Infections; Carbenicillin; Cefamandole; Cefoxitin; Chloramphenicol; Clindamycin; Clinical Trials as Topic; Humans; Metronidazole; Rats; Ticarcillin | 1981 |
Otitis media and mastoiditis due to Mycobacterium fortuitum: case report, review of four cases, and a cautionary note.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Cefoxitin; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Mastoiditis; Mycobacterium Infections; Nontuberculous Mycobacteria; Otitis Media; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
7 trial(s) available for amikacin and cefoxitin
Article | Year |
---|---|
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Skin Diseases, Bacterial; Staphylococcus | 2008 |
A comparison of two antibiotic regimens for treatment of pelvic inflammatory disease.
Topics: Acute Disease; Amikacin; Anti-Bacterial Agents; Cefoxitin; Cervix Uteri; Chlamydia trachomatis; Clindamycin; Clinical Trials as Topic; Double-Blind Method; Doxycycline; Drug Therapy, Combination; Female; Humans; Neisseria gonorrhoeae; Pelvic Inflammatory Disease; Prospective Studies; Random Allocation | 1988 |
Quantitative studies on antibiotic nephrotoxicity.
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; beta 2-Microglobulin; Cefoxitin; Cefuroxime; Clinical Trials as Topic; Drug Combinations; Female; Gentamicins; Glomerular Filtration Rate; Humans; Kidney Tubules, Proximal; Male; Middle Aged; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1980 |
A randomized comparison of cefoxitin with or without amikacin and clindamycin plus amikacin in surgical sepsis.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Cefoxitin; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Kanamycin; Male; Middle Aged; Postoperative Complications; Prospective Studies | 1981 |
Comparative clinical trials in treatment of intra-abdominal sepsis.
Topics: Abdomen; Abdominal Injuries; Abscess; Amikacin; Animals; Bacterial Infections; Carbenicillin; Cefamandole; Cefoxitin; Chloramphenicol; Clindamycin; Clinical Trials as Topic; Humans; Metronidazole; Rats; Ticarcillin | 1981 |
Cost comparison of two antimicrobial regimens for treating mixed aerobic-anaerobic infections.
Topics: Aerobiosis; Amikacin; Anaerobiosis; Anti-Bacterial Agents; Bacterial Infections; Cefoxitin; Clindamycin; Costs and Cost Analysis; Gentamicins; Humans; Tobramycin | 1981 |
[Effects of the combined therapy of heat sensitive moxibustion and acupoint injection on endometrial receptivity of hypdrosalphinx infertility in the patients after hysteroscopy and laparoscopy].
Topics: Acupuncture Points; Amikacin; Cefoxitin; Combined Modality Therapy; Female; Hot Temperature; Humans; Hysteroscopy; Infertility, Female; Injections; Laparoscopy; Lidocaine; Moxibustion; Pregnancy; Salvia miltiorrhiza | 2018 |
91 other study(ies) available for amikacin and cefoxitin
Article | Year |
---|---|
First report of plasmid-mediated qnrA1 in a ciprofloxacin-resistant Escherichia coli strain in Latin America.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Conjugation, Genetic; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Integrons; Latin America; Molecular Sequence Data; Plasmids | 2007 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Proteus mirabilis; Risk Factors; Survival Analysis; Treatment Outcome | 2007 |
Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome.
Topics: Bacteremia; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Infectious Disease Transmission, Professional-to-Patient; Integrons; Microbial Sensitivity Tests; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Sequence Analysis, DNA; Treatment Outcome | 2007 |
Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Prevalence; Switzerland | 2007 |
First occurrence of an Escherichia coli clinical isolate producing the VIM-1/VIM-2 hybrid metallo-beta-lactamase VIM-12.
Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Conjugation, Genetic; Escherichia coli; Escherichia coli Infections; Humans; Male; Microbial Sensitivity Tests; Plasmids; Recombination, Genetic | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Differential antibiotic susceptibility of Mycobacterium abscessus variants in biofilms and macrophages compared to that of planktonic bacteria.
Topics: Amikacin; Anti-Bacterial Agents; Biofilms; Cells, Cultured; Clarithromycin; Colony Count, Microbial; Host-Pathogen Interactions; Humans; Macrophages; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Plankton | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Mycobacterium; Mycobacterium Infections; Pigmentation; Species Specificity; Tigecycline | 2008 |
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
Topics: Acetyltransferases; Anti-Bacterial Agents; Bacterial Proteins; China; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Prevalence; Quinolones | 2008 |
KPC-2-producing Enterobacter cloacae and pseudomonas putida coinfection in a liver transplant recipient.
Topics: Anti-Bacterial Agents; beta-Lactamases; Enterobacter cloacae; Female; Humans; Liver Transplantation; Microbial Sensitivity Tests; Middle Aged; Pseudomonas putida; RNA, Ribosomal, 16S | 2009 |
Widespread dissemination of aminoglycoside resistance genes armA and rmtB in Klebsiella pneumoniae isolates in Taiwan producing CTX-M-type extended-spectrum beta-lactamases.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blotting, Southern; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Klebsiella pneumoniae; Taiwan | 2009 |
Nationwide survey of CTX-M-type extended-spectrum beta-lactamases among Klebsiella pneumoniae isolates in Slovenian hospitals.
Topics: Anti-Bacterial Agents; beta-Lactamases; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Hospitals; Klebsiella pneumoniae; Microbial Sensitivity Tests; Slovenia | 2009 |
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence | 2009 |
Codetection of blaOXA-23-like gene (blaOXA-133) and blaOXA-58 in Acinetobacter radioresistens: report from the SENTRY antimicrobial surveillance program.
Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Molecular Sequence Data; Plasmids; Population Surveillance; Reverse Transcriptase Polymerase Chain Reaction; Transcription, Genetic | 2009 |
Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18).
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; India; Microbial Sensitivity Tests; Molecular Sequence Data; Prevalence; Pseudomonas aeruginosa; Ribotyping | 2009 |
blaCTX-M genes in escherichia coli strains from Croatian Hospitals are located in new (blaCTX-M-3a) and widely spread (blaCTX-M-3a and blaCTX-M-15) genetic structures.
Topics: Base Sequence; beta-Lactamases; DNA Transposable Elements; Escherichia coli; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction | 2009 |
New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis.
Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Proteins; Base Sequence; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Proteus Infections; Proteus mirabilis; Quinolones; Sequence Analysis, DNA | 2009 |
Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; China; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Imipenem; India; Klebsiella; Quinolones; Thailand | 2009 |
Novel genetic environment of the carbapenem-hydrolyzing beta-lactamase KPC-2 among Enterobacteriaceae in China.
Topics: Anti-Bacterial Agents; beta-Lactamases; Blotting, Southern; Carbapenems; China; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2009 |
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
Topics: beta-Lactamases; Computational Biology; Escherichia coli; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Plasmids; United Kingdom | 2009 |
Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Integrons; Microbial Sensitivity Tests; Phenotype; Population Surveillance; Porins; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in the United States, 2007-2008: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART).
Topics: Abdomen; Amikacin; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests | 2010 |
Complete nucleotide sequence of Klebsiella pneumoniae multidrug resistance plasmid pKP048, carrying blaKPC-2, blaDHA-1, qnrB4, and armA.
Topics: Aminoglycosides; Anti-Bacterial Agents; Base Sequence; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Klebsiella pneumoniae; Models, Genetic; Molecular Sequence Data; Plasmids | 2010 |
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
Topics: Amikacin; Anti-Bacterial Agents; Carbenicillin; Cefamandole; Cefoxitin; Cefuroxime; Cephalosporins; Cephalothin; Enterobacter; Enterobacteriaceae; Escherichia coli; Klebsiella; Penicillin Resistance; Piperacillin; Proteus; Pseudomonas aeruginosa; Serratia | 1978 |
Antibiotic penetration of synovial fluid in infected and normal knee joints.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Infections; Carbenicillin; Cefazolin; Cefoxitin; Cephalothin; Escherichia coli Infections; Gentamicins; Humans; Joint Diseases; Knee Joint; Rabbits; Synovial Fluid | 1978 |
[Bactericidal kinetics of cefazolin, cefoxitin and amikacin alone and in combination (author's transl)].
Topics: Amikacin; Bacteria; Bacterial Infections; Cefazolin; Cefoxitin; Cephalosporins; Drug Synergism; Escherichia coli; Humans; Kanamycin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Proteus vulgaris; Time Factors | 1978 |
Activity of cefuroxime, cefoxitin and amikacin against Serratia marcesens.
Topics: Amikacin; Cefoxitin; Cefuroxime; Cephalosporins; Kanamycin; Microbial Sensitivity Tests; Serratia marcescens | 1979 |
In vitro activity of cefamandole, cefoxitin, cefuroxime, and carbenicillin, alone and in combination with aminoglycosides against Serratia marcescens.
Topics: Amikacin; Aminoglycosides; Carbenicillin; Cefamandole; Cefoxitin; Cefuroxime; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Serratia marcescens; Tobramycin | 1979 |
Klebsiella pneumoniae: in vitro antibacterial activity of cefoxitin and amikacin, alone and in combination.
Topics: Amikacin; Cefoxitin; Drug Interactions; Kanamycin; Klebsiella pneumoniae; Microbial Sensitivity Tests | 1979 |
[Pharmacokinetic study of antibiotics in human respiratory tract (author's transl)].
Topics: Adult; Aged; Amikacin; Amoxicillin; Anti-Bacterial Agents; Bronchi; Bronchitis; Cefoxitin; Female; Humans; Kinetics; Male; Middle Aged; Oleandomycin | 1978 |
Activity of combinations of antimicrobial agents against Bacteroides fragilis.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Carbenicillin; Cefoxitin; Chloramphenicol; Clindamycin; Drug Combinations; Drug Interactions; Drug Synergism; Erythromycin; Metronidazole; Penicillins; Tetracycline | 1976 |
[Infectious complications after surgery of esophageal pathology. Apropos of 60 cases].
Topics: Aged; Amikacin; Bacterial Infections; Cefoxitin; Esophageal Diseases; Female; Gram-Negative Bacteria; Humans; Lung Diseases; Male; Middle Aged; Parenteral Nutrition; Postoperative Complications; Premedication; Prospective Studies; Urinary Tract Infections | 1989 |
Disseminated Mycobacterium chelonae ssp. abscessus in an immunocompetent host and with a known portal of entry.
Topics: Adult; Amikacin; Cefoxitin; Drug Therapy, Combination; Female; Humans; Immunocompetence; Mycobacterium Infections; Skin; Skin Diseases, Infectious; Wounds, Penetrating | 1989 |
In vitro effect of cefoxitin and amikacin combination on M. fortuitum.
Topics: Amikacin; Cefoxitin; Culture Media; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Mycobacterium | 1988 |
[Clinical evaluation of combination therapy with cefoxitin and amikacin in complicated urinary tract infections].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Cefoxitin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Urinary Tract Infections | 1986 |
[Combined clinical effect of amikacin and cefoxitin in patients with severe infections complicated by hematological diseases].
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Cefoxitin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Leukemia; Male; Middle Aged | 1987 |
Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefoxitin; Drug Combinations; Erythromycin; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Sulfamethoxazole; Sulfisoxazole; Sulfonamides; Tetracyclines; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
Cefoxitin, amikacin, and Pseudomonas aeruginosa resistance.
Topics: Amikacin; Aminoglycosides; Cefoxitin; Drug Resistance, Microbial; Humans; Kanamycin; Pseudomonas aeruginosa; Spain | 1982 |
In vitro susceptibility of cephalothin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to Amikacin and selected new beta-lactam agents.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefoxitin; Cephalothin; Cephamycins; Drug Resistance, Microbial; Enterobacteriaceae; Kanamycin; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa | 1982 |
[Treatment of type-b H. influenzae meningitis resistant to ampicillin and chloramphenicol].
Topics: Amikacin; Ampicillin; Cefotaxime; Cefoxitin; Chloramphenicol; Female; Gentamicins; Humans; Infant; Infant, Newborn; Male; Meningitis, Haemophilus; Penicillin Resistance; Rifampin | 1983 |
Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model.
Topics: Agranulocytosis; Amikacin; Animals; Anti-Bacterial Agents; Azlocillin; Cefotaxime; Cefoxitin; Ceftizoxime; Disease Models, Animal; Drug Combinations; Female; Hydrogen-Ion Concentration; Kanamycin; Microbial Sensitivity Tests; Neutropenia; Penicillins; Protein Binding; Pseudomonas Infections; Rabbits | 1984 |
[The determination of pharmacokinetic parameters from surveillance protocols of sepsis therapy].
Topics: Amikacin; Cefoxitin; Computers; Drug Therapy, Combination; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Metabolic Clearance Rate; Penicillin G; Sepsis | 1983 |
In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteria.
Topics: Amikacin; Ampicillin; Carbenicillin; Cefoxitin; Cefuroxime; Cephalosporins; Cephamycins; Clindamycin; Gram-Negative Aerobic Bacteria; Gram-Negative Anaerobic Bacteria; Haemophilus influenzae; Moxalactam; Oxacillin | 1980 |
Disseminated disease due to Mycobacterium chelonei treated with amikacin and cefoxitin. Absence of killing with either agent and possible role of granulocytes in clinical response.
Topics: Adult; Amikacin; Cefoxitin; Drug Resistance, Microbial; Granulocytes; Humans; Kanamycin; Lymphoma; Male; Mycobacterium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Neutropenia; Nontuberculous Mycobacteria; Skin Diseases, Infectious | 1984 |
Empiric antibiotic therapy with an amikacin-carbenicillin-cefoxitin combination in granulocytopenic febrile patients--a clinical report.
Topics: Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Carbenicillin; Cefoxitin; Drug Therapy, Combination; Female; Fever; Humans; Kanamycin; Leukemia; Lymphoma; Male; Middle Aged | 1983 |
[Combined action of cephamycin and aminoglycoside antibiotics].
Topics: Amikacin; Aminoglycosides; Animals; Bacteria; Cefoxitin; Dibekacin; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Gentamicins; Kanamycin; Male; Mice | 1983 |
Cefoxitin: synergism with aminoglycosides in vitro.
Topics: Amikacin; Cefoxitin; Dibekacin; Drug Synergism; Escherichia coli; Gentamicins; Kanamycin; Pseudomonas aeruginosa; Staphylococcus aureus; Tobramycin | 1981 |
[Antibacterial effect of N-formimidoyl-thienamycin in combination with amikacin, cefoxitin and fosfomycin on K. pneumoniae and P. aeruginosa].
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Drug Antagonism; Drug Synergism; Fosfomycin; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins | 1982 |
In vitro susceptibility of mycobacteria species other than Mycobacterium tuberculosis to amikacin, cephalosporins and cefoxitin.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Cephalosporins; Microbial Sensitivity Tests; Mycobacterium | 1982 |
[Clinical experience with non-specific broad-spectrum antibacterial chemotherapy (author's transl)].
Topics: Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Bacterial Infections; Cefoxitin; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Penicillins; Tobramycin | 1982 |
[Treatment of bacterial infection in acute leukemia, quadruple chemotherapy using CFX, AMK, TIPC and LCM (author's transl)].
Topics: Acute Disease; Adult; Amikacin; Bacterial Infections; Cefoxitin; Drug Therapy, Combination; Humans; Infusions, Parenteral; Kanamycin; Leukemia; Lincomycin; Middle Aged; Penicillins; Ticarcillin | 1980 |
Assays of serum aminoglycoside levels by BACTEC 460 in the presence of cefamandole and cefoxitin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefamandole; Cefoxitin; Cephalosporins; Gentamicins; Humans; Methods; Tobramycin | 1981 |
Mycobacterium chelonae infection following a total knee arthroplasty.
Topics: Aged; Amikacin; Cefoxitin; Drug Therapy, Combination; False Negative Reactions; Female; Humans; Knee Prosthesis; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Prosthesis-Related Infections; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
Pyogenic arthritis of the hip following an occult open fracture of the pubic rami--a case report.
Topics: Adult; Amikacin; Arthritis, Infectious; Cefoxitin; Drug Therapy, Combination; Female; Fractures, Open; Hip Joint; Humans; Klebsiella Infections; Pelvic Bones; Pseudomonas Infections | 1996 |
Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Culture Media; Doxycycline; Humans; Imipenem; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Sulfamethoxazole; Tobramycin | 1999 |
Edwardsiella tarda bacteraemia--complicated by acute pancreatitis and pyomyoma.
Topics: Acute Disease; Amikacin; Anti-Bacterial Agents; Bacteremia; Blood Chemical Analysis; Cefoxitin; Cephamycins; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Hysterectomy; Middle Aged; Myoma; Ovariectomy; Pancreatitis; Tomography, X-Ray Computed; Uterus | 1999 |
Mycobacterium fortuitum osteomyelitis in a peripheral blood stem cell transplant recipient.
Topics: Administration, Oral; Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Biopsy; Cefoxitin; Cephamycins; Ciprofloxacin; Debridement; Hematopoietic Stem Cell Transplantation; Humans; Magnetic Resonance Imaging; Male; Microbial Sensitivity Tests; Multiple Myeloma; Mycobacterium fortuitum; Osteomyelitis; Tibia | 2000 |
[A case of bronchial ulcer due to infection by Mycobacterium abscessus].
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bronchial Diseases; Bronchitis; Cefoxitin; Clarithromycin; Drug Therapy, Combination; Humans; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Tracheitis; Ulcer | 2004 |
Bacteremia caused by the novel species Mycobacterium canariasense.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Bacteremia; Catheterization, Central Venous; Catheters, Indwelling; Cefoxitin; Device Removal; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Mycobacterium; Mycobacterium Infections; Retrospective Studies | 2006 |
Disseminated nontuberculous mycobacterial infections in sickle cell anemia patients.
Topics: Acetamides; Adolescent; Amikacin; Anemia, Sickle Cell; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Linezolid; Microbial Sensitivity Tests; Mycobacterium fortuitum; Mycobacterium Infections; Oxazolidinones; Treatment Outcome | 2006 |
Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefoxitin; Chemical and Drug Induced Liver Injury; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Humans; Liver; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Neutropenia; Nontuberculous Mycobacteria; Retrospective Studies; Sputum; Thrombocytopenia; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus.
Topics: Amikacin; Antibiotics, Antitubercular; Cefoxitin; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Retrospective Studies; Sputum; Treatment Outcome | 2011 |
[Mycobacterium abscessus pulmonary infection treated with tigecyclin-amikacin and cefoxitin in a diabetic patient].
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Diabetes Complications; Drug Therapy, Combination; Female; Humans; Lung Diseases; Middle Aged; Minocycline; Mycobacterium Infections, Nontuberculous; Tigecycline | 2011 |
Positive culture for extended-spectrum β-lactamase during acute prostatitis after prostate biopsy is a risk factor for progression to chronic prostatitis.
Topics: Aged; Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Blood; Cefoxitin; Disease Progression; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Image-Guided Biopsy; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Prostate; Prostatitis; Quinolones; Urine | 2013 |
Clinical isolates of Mycobacterium abscessus in Guangzhou area most possibly from the environmental infection showed variable susceptibility.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; China; Chromatography, Gas; Ciprofloxacin; Clarithromycin; Imipenem; Microbial Sensitivity Tests; Mycobacterium; Polymerase Chain Reaction; Random Amplified Polymorphic DNA Technique | 2013 |
[Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
Topics: Acetamides; Amikacin; Anti-Bacterial Agents; Cefoxitin; Clarithromycin; Culture Media; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Oxazolidinones; Sensitivity and Specificity; Tobramycin | 2013 |
Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients.
Topics: Adult; Amikacin; beta-Lactamases; beta-Lactams; Cefoxitin; Ciprofloxacin; Drug Resistance, Bacterial; End Stage Liver Disease; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Preoperative Period; Risk Factors; Severity of Illness Index | 2014 |
[The analysis of species identification and susceptibility testing of Mycobacterium abscessus].
Topics: Amikacin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Azithromycin; Cefoxitin; Clarithromycin; Humans; Nontuberculous Mycobacteria; RNA, Ribosomal, 16S | 2014 |
Trends in Susceptibility Rates and Extended-Spectrum β-Lactamase Production of Klebsiella pneumoniae in Bloodstream Infections Across the United States Veterans Affairs Healthcare System.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cefepime; Cefoxitin; Ceftazidime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Ertapenem; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sulbactam; United States; United States Department of Veterans Affairs | 2015 |
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2016 |
Tattoo-associated mycobacterial infections: an emerging public health issue.
Topics: Amikacin; Anti-Bacterial Agents; Australia; Cefoxitin; Clarithromycin; Drug Therapy, Combination; Humans; Male; Mycobacterium Infections; Public Health; Tattooing; Young Adult | 2015 |
Oral Macrolide Therapy Following Short-term Combination Antibiotic Treatment of Mycobacterium massiliense Lung Disease.
Topics: Administration, Oral; Amikacin; Anti-Bacterial Agents; Cefoxitin; Drug Therapy, Combination; Female; Humans; Imipenem; Macrolides; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Prospective Studies; Sputum; Treatment Outcome | 2016 |
Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Clarithromycin; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Treatment Failure | 2016 |
Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Imipenem; Linezolid; Microbial Sensitivity Tests; Minocycline; Mutation; Mycobacterium; Tigecycline | 2017 |
Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefoxitin; Community-Acquired Infections; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Turkey; Urinary Tract Infections | 2017 |
In vitro activity between linezolid and other antimicrobial agents against Mycobacterium abscessus complex.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; DNA-Directed RNA Polymerases; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Tigecycline | 2018 |
Mycobacterium abscessus Infection During Ustekinumab Treatment in Crohn's Disease: A Case Report and Review of the Literature.
Topics: Amikacin; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Cefoxitin; Crohn Disease; Drug Administration Schedule; Female; Humans; Ileal Diseases; Injections, Subcutaneous; Interleukin-12 Subunit p40; Magnetic Resonance Imaging; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Thigh; Treatment Outcome; Ustekinumab | 2018 |
AmpC beta-lactamases in Klebsiella pneumoniae: An emerging threat to the paediatric patients.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefoperazone; Cefoxitin; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross-Sectional Studies; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Bacterial; Female; Hospitals, Pediatric; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Pakistan; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2018 |
Molecular and Phenotypic Characteristics of
Topics: Agriculture; Amikacin; Ampicillin; Animals; Cefoxitin; China; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Mink; Tetracycline | 2019 |
Rare case of pacemaker infection with
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Arrhythmias, Cardiac; Cefoxitin; Clarithromycin; Clofazimine; Drug Resistance, Bacterial; Epidural Abscess; Heroin Dependence; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Osteomyelitis; Pacemaker, Artificial; Prosthesis-Related Infections | 2019 |
Effect of the Association and Evaluation of the Induction to Adaptation of the (+)-α-pinene with Commercial Antimicrobials against Strains of Escherichia coli.
Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Bicyclic Monoterpenes; Cefepime; Cefoxitin; Ceftazidime; Escherichia coli; Microbial Sensitivity Tests | 2020 |
Radiographic severity and treatment outcome of Mycobacterium abscessus complex pulmonary disease.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Cefoxitin; Drug Therapy, Combination; Female; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Pneumonia, Bacterial; Radiography, Thoracic; Retrospective Studies; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome | 2021 |
Analysis of drug resistance genes of integrons in clinical isolates of Escherichia coli from elderly bloodstream infections.
Topics: Aged; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cefoxitin; Clavulanic Acid; Drug Resistance; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Integrons; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Sepsis; Ticarcillin; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Unraveling antibiotic resistance mechanisms in Mycobacterium abscessus: the potential role of efflux pumps.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Clarithromycin; Clofazimine; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Thioridazine; Tigecycline; Verapamil | 2022 |
[Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Doxycycline; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Tobramycin | 2023 |